References
- Lobl T J. Androgen transport proteins: physical properties, hormonal regulation, and possible mechanism of TeBG and ABP action. Arch Androl 1981; 7: 133–51
- Brien T G. Human corticosteroid binding globulin. Clin Endocrinol 1981; 14: 193–212
- Böttiger L E., Boman G, Eklund G, Westerholm B. Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content. Lancet 1980; 1097–101
- Poller L. Oral contraceptives, blood clotting and thrombosis. Br Med Bull 1978; 34: 151–6
- Hunter D J S, Anderson A B M, Haddon M. Changes in coagulation factors in postmenopausal women on ethinylestradiol. Br J Obstet Gynaecol 1979; 86: 488–90
- Bonnar J, Sabra A, Daly L, Carroll M E. Haemostasis and oral contraception. Contraception-fertilite-sexu-alite 1985; 11: 1133–7
- Ludwig H. A position paper on the relation between oral contraceptives and blood coagulation. Contraception 1979; 20: 257–61
- Leff B, Henriksen R A., Owen W G. Effect of oral contraceptive use on platelet prothrombin converting (platelet Factor 3) activity. Thromb Res 1979; 15: 631–8
- Bergink E W., Holma P, Pyörälä T. Effects of oral contraceptive combinations containing levonorgestrel or desogestrel on serum proteins and androgen binding. Scan J Clin Lab Invest 1981; 41: 663–8
- Mickelson K E., Petra P H. A filter assay for the sex steroid binding protein of human serum. FEBS Lett 1974; 44: 34–8
- Schiller H S., Petra P H. A filter assay for the corticosteroid binding globulin of human serum. J Steroid Biochem 1979; 7: 55–9
- Roka L. Aktuelle Diagnostik. Boehringer, Mannheim 1977
- Bergink E W., Hamburger A D., de Jager E, van der Vies J. Binding of a contraceptive progestogen Org 2969 and its metabolites to receptor proteins and human sex hormone binding globulin. J Steroid Biochem 1981; 14: 175–83
- Gaspard U J., Romus M A., Gillain D, Duvivier J, Demey-Ponsart E, Franchimont P. Plasma hormone levels in women receiving new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel. Contraception 1983; 27: 577–90
- Philo R D., Gaffney P J. Comparison of antithrombin III assays using biological and chromogenic substrates. Br J Haematol 1982; 50: 147–56
- Bruni V, Rosati D, Bucciantini S, et al. Platelet and coagulation functions during triphasic oestrogen—progestogen treatment. Contraception 1986; 33: 39–46
- Bertolini S, Cordera R, Elicio N, et al. Metabolic and haemocoagulative changes induced by three low dose oral contraceptive (OC) formulations. 4th European Symposium on Metabolism, Padua, 1985
- Tuimala R, Korhonen M, Kortesluoma M. Effect of the oral contraceptive combination 0.150 mg desogestrel + 0.020 mg ethinylestradiol on serum lipids. SHBG, glycosylated proteins and plasma antithrombin III activity in healthy women. 37–39, This supplement